April 2022

A listing of the individual articles included in the Jurisdiction E Medicare B News bulletin dated April 2022 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2021 1099 Tax Forms Available on NMP
2022 Annual Update of HCPCS Codes for SNF CB Update CR12487
AIF for Calendar Year (CY) 2022 and Productivity Adjustment CR12488
Amniotic and/or Placental Derived Products (Also Known As "Skin Substitutes")
An Omnibus CR Covering: (1) Removal of Two NCD, (2) Updates to the MNT Policy, and (3) Updates to the PR, CR, and ICR Conditions of Coverage CR12613
Anesthesia Overpayments - Resolved 03/10/22 Alert
April 2022 Quarterly ASP Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files CR12559
April 2022 Update of the Ambulatory Surgical Center (ASC) Payment System CR12679
April Quarterly Update for 2022 DMEPOS Fee Schedule CR12654
Billing and Coding Facet Joint Interventions for Pain Management Local Coverage Article - R1 - Effective May 01, 2022
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) Final Billing and Coding Article - Effective April 17, 2022
Billing and Coding Outpatient Cardiac Rehabilitation - R7 - Effective January 1, 2022
Billing and Coding Outpatient Cardiac Rehabilitation - R7 - Effective January 1, 2022
Billing and Coding: 4Kscore Assay (A57336) - R2 - Effective March 24, 2022
Billing and Coding: Cataract Surgery in Adults (A57195) - R3 - Effective January 1, 2022
Billing and Coding: Complex Drug Administration Coding - R7 - Effective April 9, 2022
Billing and Coding: Home PT/INR Monitoring (G0249) Billing and Coding - R2 - Effective April 29, 2020
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) R7 - Effective January 1, 2022
Billing and Coding: Influenza Diagnostic Tests (A59055) - Effective March 09, 2022
Billing and Coding: JW Modifier Billing Guidelines - R2 - Effective April 28, 2020
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R12 - Effective October 01, 2021
Billing and Coding: MolDX: BDX-XL2 (A57356) - R2 - Effective April 22, 2021
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R3 - Effective October 1, 2021
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R3 - Effective October 1, 2021
Billing and Coding: MolDX: Corus CAD Assay (A57415) Retirement - Effective February 15, 2022
Billing and Coding: MolDX: FDA-Approved BRAF Tests (A54418) - R5 - Effective March 03, 2022
Billing and Coding: MolDX: FDA-Approved EGFR Tests (A54422) - R4 - Effective March 03, 2022
Billing and Coding: MolDX: FDA-Approved KRAS Tests (A54498) - R6 - Effective March 03, 2022
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R6 - Effective March 17, 2022
Billing and Coding: MolDX: MammaPrint (A54445) - R7 - Effective January 01, 2022
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - Effective December 26, 2021
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R5 - Effective January 01, 2022
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R1 - Effective April 17, 2022
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58168) - R1 - Effective November 25, 2021
Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (A57338) - R15 - Effective February 03, 2022
Billing and Coding: MolDX: myPath® Melanoma Assay (A57626) - R3 - Effective January 01, 2022
Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® (A55295) - R7 - Effective January 06, 2022
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R1 - Effective January 01, 2022
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R3 - Effective January 01, 2022
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R1 - Effective January 06, 2022
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R3 - Effective February 24, 2022
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R3 - Effective February 24, 2022
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R3 - Effective February 24, 2022
Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (A58181) - R2 - Effective January 01, 2022
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R2 - Effective January 01, 2022
Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer (A55624) - R7 - Effective January 01, 2022
Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer (A55624) - R8 - Effective March 16, 2022
Billing and Coding: MolDX: Testing of Multiple Genes (A58120) - R2 - Effective February 10, 2022
Billing and Coding: Platelet Rich Plasma - Retirement - Effective January 23, 2022
Billing and Coding: Positron Emission Tomography Scans Coverage - R32 - Article effective January 1. 2022
— 50 Items per Page
Showing 1 - 50 of 142 results.